Vtv therapeutics inc. (VTVT)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Dec'14
Assets
Current assets:
Cash and cash equivalents

406

1,777

2,436

1,462

4,959

1,683

3,766

1,163

6,535

11,758

20,488

32,513

45,150

51,505

51,058

63,841

75,501

88,003

97,010

-

1,384

Restricted cash

-

-

-

-

-

-

-

-

-

-

281

-

-

-

-

-

-

-

-

-

-

Restricted cash and cash equivalents

2,500

-

-

-

-

-

-

-

-

162

-

-

-

0

-

-

-

-

-

-

130

Accounts receivable, net

5

5

10

1,822

-

-

-

2,270

210

8,000

-

-

-

0

0

0

206

69

-

-

-

Prepaid expenses and other current assets

591

806

870

145

419

666

1,006

264

471

442

725

639

782

612

1,058

423

1,346

1,114

799

-

97

Current deposits

-

250

251

367

34

1,124

1,124

2,311

2,256

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

3,502

2,838

3,567

3,796

5,412

3,473

5,896

6,008

9,472

20,362

21,494

33,152

45,932

52,117

52,116

64,264

77,053

89,186

97,809

-

1,611

Restricted cash and cash equivalents, long-term

2,500

2,500

2,500

2,500

2,500

2,500

2,500

2,500

2,500

2,500

-

-

-

-

-

-

-

-

-

-

-

Note receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,594

Property and equipment, net

434

461

46

54

62

70

177

202

241

283

310

374

426

444

493

561

545

624

669

-

3,778

Operating lease right-of-use assets

529

543

85

167

246

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term investments

2,480

2,480

2,480

2,480

2,480

2,480

2,480

2,480

2,480

2,480

-

-

-

-

-

-

-

-

-

-

-

Long-term deposits

444

444

444

75

36

36

36

36

36

2,292

-

-

-

1,934

-

-

-

-

-

-

-

Receivable due from a related party, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

800

Employee loans receivable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

24

24

-

48

-

58

Other long-term assets

-

-

-

-

-

-

-

-

-

-

2,251

2,253

1,971

-

2,103

1,934

1,937

1,722

1,669

-

110

Total assets

7,389

9,266

9,122

9,072

10,736

8,559

11,089

11,226

14,729

27,917

24,055

35,779

48,329

54,495

54,715

66,783

79,559

91,532

100,195

-

12,951

Liabilities, Redeemable Noncontrolling Interest and Stockholders’ Deficit
Current liabilities:
Accounts payable and accrued expenses

7,395

7,068

6,898

8,326

6,244

7,702

8,965

13,144

11,296

13,901

10,120

10,734

11,105

11,413

10,156

9,490

7,955

6,627

5,240

-

3,079

Current portion of operating lease liabilities

136

110

91

178

259

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of contract liabilities

31

31

31

27

839

1,752

6,747

10,114

-

8,757

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

406

312

622

880

516

-

1,752

Current portion of deferred revenue

-

-

-

-

-

-

-

-

8,754

-

-

-

4

21

21

21

97

219

320

-

-

Current portion of notes payable

4,408

6,172

7,442

8,646

9,167

9,383

9,597

8,229

6,771

4,271

2,083

521

-

-

-

-

-

-

-

-

-

Total current liabilities

11,970

13,381

14,462

17,177

16,509

18,837

25,309

31,487

26,821

26,929

12,203

11,255

11,109

11,434

10,583

9,823

8,674

7,726

6,076

-

6,864

Debt - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

27,310

Debt, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,110

Fair value of contingent distribution

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26,359

Notes payable, net of current portion

-

-

1,363

2,185

4,014

6,330

8,611

10,863

13,091

15,316

17,228

18,516

18,761

11,058

-

-

-

-

-

-

6,594

Contract liabilities, net of current portion

1,025

1,033

1,040

1,052

1,067

1,067

595

603

-

4,497

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, net of current portion

795

831

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, net of current portion

-

-

-

-

-

-

-

-

2,436

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability, related party

2,964

2,601

1,878

1,240

1,515

2,436

382

201

517

492

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

260

260

260

260

260

260

258

256

255

290

285

273

269

433

-

-

-

-

53

-

4,434

Short-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

155

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

225

230

237

245

-

-

1,878

Total liabilities

17,014

18,106

19,003

21,914

23,365

28,930

35,155

43,410

43,120

47,524

29,716

30,044

30,139

22,925

10,808

10,053

8,911

7,971

6,129

-

73,671

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

-

0

Redeemable convertible preferred units

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

438,086

Redeemable noncontrolling interest

52,196

40,183

37,268

37,060

45,106

62,482

19,912

39,413

120,397

131,440

130,642

112,145

141,659

122,515

155,147

136,250

133,670

161,531

188,251

-

-

Stockholders’ deficit:
Members' deficit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-498,806

Common stock value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Additional paid-in capital

190,200

183,858

175,990

167,125

162,249

150,595

144,617

134,587

128,796

127,682

127,036

126,077

125,118

124,212

122,838

122,137

119,505

117,686

117,131

-

-

Accumulated deficit

-252,700

-233,522

-223,725

-217,557

-220,489

-233,883

-188,985

-206,525

-277,913

-279,058

-263,668

-232,816

-248,916

-215,486

-234,407

-201,986

-182,856

-195,985

-211,645

-

-

Common stock receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Total stockholders’ deficit attributable to vTv Therapeutics Inc.

-61,821

-49,023

-47,149

-49,902

-57,735

-82,853

-43,978

-71,597

-148,788

-151,047

-136,303

-106,410

-123,469

-90,945

-111,240

-79,520

-63,022

-77,970

-94,185

0

-498,806

Total liabilities, redeemable noncontrolling interest and stockholders’ deficit

7,389

9,266

9,122

9,072

10,736

8,559

11,089

11,226

14,729

27,917

24,055

35,779

48,329

54,495

54,715

66,783

79,559

91,532

100,195

-

12,951

Class A Common Stock [Member]
Common stock value

447

409

354

298

273

203

-

-

-

97

-

-

-

-

-

-

-

-

-

-

-

Total stockholders’ deficit attributable to vTv Therapeutics Inc.

447

409

354

298

273

203

-

-

-

97

-

-

-

-

-

-

-

-

-

-

-

Class B Common Stock [Member]
Common stock value

232

232

232

232

232

232

-

-

-

232

-

-

-

-

-

-

-

-

-

-

-

Total stockholders’ deficit attributable to vTv Therapeutics Inc.

232

232

232

232

232

232

-

-

-

232

-

-

-

-

-

-

-

-

-

-

-